Duane Boise

Court Orders DEA To Respond To Medical Marijuana Company's Request For Bulk Manufacturing Registration
Cannabis Research Company Submits FDA Responses For Gel Capsule Approval
Cannabis Co. Suing DEA Over Ignored Application: Why It Matters
Cannabis Research Company Submits FDA Responses For Gel Capsule Approval
Cannabis Co. Suing DEA Over Ignored Application: Why It Matters
Congress Gets Warning Letter: Be Aware The DEA Is Breaking The Law, Cannabis Company Says
MMJ's THC-CBD Drug Ready For MS And Huntington's Disease Clinical Trials, Awaiting DEA And FDA Final Approvals

Duane Boise Recent News

DEA Stonewalling MMJ's MS & Huntington's Disease Clinical Trials For 3 Years
MMJ companies are building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in multiple sclerosis and Huntington's disease. MMJ was awarded the much coveted orphan drug designation from the FDA for its planned Huntington's disease trials, and has also received a D
DEA Delays Medical Marijuana Clinical Trials Yet Illicit Market Continues To Thrive
As states legalize marijuana, some as long as 10 years ago, many are beginning to realize the public health and safety implications of a variety of new high-potency products
'DEA Has Blown It Again' - MMJ Request Federal Court Action For Emergency Motion To Expedite
Megan Sheehan of Sheehan & Associates, Attorneys representing MMJ International Holdings and MMJ BioPharma Cultivation etal, scheduled to execute on clinical trials in Huntington's disease and multiple sclerosis, filed a motion in federal court against the Drug Enforcement Administration, asking the federal court for "an emergency motion for irrepa
DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know So Far
Two Rhode Island cannabinoid research laboratories are suing the DEA for standing in the way of what they consider to be the crucial development of pharmaceutical-grade cannabis products for use in clinical trials for the treatment of Multiple Sclerosis and Huntington's Disease. 
DEA Delays Production Of Marijuana Drug As Potential Treatment For Multiple Sclerosis And Huntington's Disease
MMJ International Holdings, in collaboration with a specialty pharmaceutical solutions company, has been manufacturing gelatin capsule medicines based on compounds found in cannabis. The company will investigate these in clinical trials as potential treatments for multiple sclerosis (MS) and Huntington's disease (HD).
STEM Solutions LLC Builds Federally Authorized Cannabis Lab For MMJ BioPharma Labs
MMJ BioPharma Labs recently became one of the only federally authorized labs dedicated to cannabis extraction, research, and development with their approved DEA Analytical Lab Registration for schedule 1-4 drugs.